• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 IV - How Do I Use Them
 

IV - How Do I Use Them

on

  • 12,011 views

 

Statistics

Views

Total Views
12,011
Views on SlideShare
3,105
Embed Views
8,906

Actions

Likes
0
Downloads
154
Comments
0

7 Embeds 8,906

http://pharmacologycorner.com 8711
http://pharmamotion.com.ar 138
http://translate.googleusercontent.com 45
http://www.slideshare.net 8
http://webcache.googleusercontent.com 2
http://www.letusinproxy.com 1
http://www.google.com.sa 1
More...

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

     IV - How Do I Use Them IV - How Do I Use Them Presentation Transcript

    • DIURETICS How do they work? What do they do? When do I use them? HOW DO I USE THEM?
    • CONCEPT OF CEILING DOSE Ceiling [Diuretic] TL Ceiling Effect Log [Diuretic] TL Fractional Excretion of Sodium (%)
    • CONCEPT OF CEILING DOSE Dose of Diuretic that Achieves a Ceiling [Diuretic] in the Tubular Lumen. Said Differently Dose of Diuretic that Yields a Near-Maximal Diuretic Response.
    • CONCEPT OF CEILING DOSE EFFECT < Ceiling Effect Ceiling Effect Ceiling Effect ACTUAL DOSE < Ceiling Dose Ceiling Dose > Ceiling Dose
    • CONCEPT OF CEILING DOSE Exceeding Ceiling Dose Yields: Pointless, and possibly harmful, to exceed ceiling dose of diuretic!! No Additional Effect Possible Adverse Effects
    • DETERMINANTS OF CEILING DOSE VARIABLE
      • Ceiling Dose Depends on:
        • Diuretic
        • Disease
      Increased Potency Decrease CEILING DOSE Decreased Tubular Transport (e.g., ARF/CRF) Increase Increased Binding to Urinary Proteins (e.g., Nephrotic Syndrome) Increase
    • CEILING DOSES FOR I.V. LOOP DIURETICS (in mgs) CIRRHOSIS HEART FAILURE 40 to 80 1 to 2 10 to 20 NEPHROTIC SYNDROME AFR/CRF Moderate AFR/CRF Severe 160 to 200 8 to 10 50 to 100 80 to 160 4 to 8 20 to 50 80 to 120 2 to 3 20 to 50 40 to 80 1 to 2 10 to 20 Furosemide Bumetanide Torsemide Protein Binding Increases Ceiling Dose Impaired Delivery Increases Ceiling Dose
    • CONVERTING I.V. DOSING TO ORAL DOSING BIOAVAILABILITY CONVERSION FACTOR ~ 50% (highly variable) ~ 100% ~ 100% 2 or higher 1 1 Furosemide Bumetanide Torsemide
    • DETERMINANTS OF CEILING EFFECT VARIABLE
      • Ceiling Effect Depends on:
        • Diuretic
        • Disease
      Diuretic Loop > Thiazide > K-Sparing CEILING EFFECT Disease Diminished Nephron Response in Nephrotic Syndrome, Cirrhosis, & Heart Failure.
    • MECHANISMS OF DIURETIC RESISTANCE MECHANISM Patient Counseling SOLUTION Patient Counseling Push to Ceiling Dose Noncompliance NSAIDS Decreased Tubular Transport (e.g., ARF & CRF) Bed Rest Decreased RBF
    • MECHANISMS OF DIURETIC RESISTANCE (Continued) MECHANISM SOLUTION Bed Rest More Frequent Dosing or Continuous Infusion Combination Therapy (Sequential Blockade) Changes in “Volume Hormones” (SNS, RAS, ADH & ANF) Compensation by Distal Nephron Diminished Nephron Response (CHF, Cirrhosis, Nephrotic Syndrome)
    • MECHANISMS OF DIURETIC RESISTANCE Proximal Distal Na Na Proximal Distal Na Proximal Distal Na Na Na Proximal Distal Na Na Acute Loop Chronic Loop Chronic Loop + Thiazide
    • MECHANISMS OF DIURETIC RESISTANCE (Continued) MECHANISM SOLUTION Bed Rest More Frequent Dosing or Continuous Infusion Combination Therapy (Sequential Blockade) Changes in “Volume Hormones” (SNS, RAS, ADH & ANF) Compensation by Distal Nephron Diminished Nephron Response (CHF, Cirrhosis, Nephrotic Syndrome)
    • RATIONALE FOR MORE FREQUENT DOSING OR CONTINUOUS I.V. INFUSION [Diuretic] TL Ceiling [Diuretic] TL [Diuretic] TL Ceiling Ceiling
    • CEILING DOSES FOR CONTINUOUS I.V. INFUSION OF LOOP DIURETICS (in mgs per hour) LOADING DOSE (in mgs) CrCl < 25 10 0.5 5 10 to 20 0.5 to 1 5 to 10 20 to 40 1 to 2 10 to 20 40 1 20 Furosemide Bumetanide Torsemide CrCl: 25 to 75 CrCl > 75
    • WHAT HAPPENS WHEN [DIURETIC] IN TUBULAR LUMEN IS LESS THAN CEILING?? Postdiuresis Sodium Retention!!
    • RATIONALE FOR LOW SODIUM DIET A low sodium diet attenuates postdiuretic sodium retention, thereby lowering diuretic requirements!! Major Problem is Compliance
    • IMPORTANT DRUG INTERACTIONS NSAIDS Salt Decongestants Probenecid Hyperkalemia- Induced by K-Sparing Diuretics Enhanced Ototoxicity of Loop Diuretic Diminished Diuretic Response ACE Inhibitors Beta-Blockers K Supplements K-Sparing Diuretics Heparin Ototoxic Drugs
    • ARF/CRF Nephrotic Syndrome Cirrhosis Mild CHF Severe/Moderate CHF
      • DROP Thiazide &ADD Loop Diuretic:
        • 1) Titrate Single Daily Dose to Ceiling
        • 2) Optimize Frequency of Ceiling Dose
          • Furosemide: up to 4X daily
          • Bumetanide: up to 6X daily
          • Torsemide: up to 3X daily
      • ADD Thiazide Diuretic:
        • CrCl > 50, use 25 to 50 mg/d HCTZ
        • CrCl 20 to 50, use 50 to 100 mg/d HCTZ
        • CrCl < 20, use 100 to 200 mg/d HCTZ
      • ADD K-Sparing Diuretic:
        • If CrCl > 75
        • If Urinary [Na]:[K] ratio is < 1
      • (Note: May add K-Sparing Diuretic to Loop
      • and/or Thiazide Diuretic at Any Point in Algorithm
      • for K Homeostasis.)
      While Maintaining Other Diuretics, Switch Loop Agent to Continuous Infusion Spironolactone Titrated to 400 mg Daily.
      • ADD Thiazide:
      • If CrCl > 50
      • 50 to 100 mg/d HCTZ
    •